Task: Answer the multiple-choice question.
Query: Which drug exhibits a -26.796% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a CC(=O)c1ccc(S(=O)(=O)Nc2ccc(C(=O)NCC(c3cccs3)N3CCOCC3)cc2)cc1
b O=c1oc(-c2ccc(Br)o2)nc2ccccc12
c CCC(C)c1nc2c(c(N3CCC3=O)c1-c1ccccc1)CCCC2
d Cc1cccc(-c2nnc(SCc3cc(=O)[nH]c4ccccc34)n2C)c1
e Cc1ccc(C2N3CC4([N+](=O)[O-])CN2CC([N+](=O)[O-])(C3)C4(C)C)cc1
Answer: c. CCC(C)c1nc2c(c(N3CCC3=O)c1-c1ccccc1)CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)c1nc2c(c(N3CCC3=O)c1-c1ccccc1)CCCC2
CCC(C)c1nc2c(c(N3CCC3=O)c1-c1ccccc1)CCCC2
1-(2-butan-2-yl-3-phenyl-5,6,7,8-tetrahydroquinolin-4-yl)azetidin-2-one